STOCK TITAN

The Oncology Institute to Participate at the Credit Suisse 31st Annual Healthcare Conference

The Oncology Institute, Inc. (NASDAQ: TOI) announced that CEO Brad Hively and CFO Mihir Shah will speak at the Credit Suisse 31st Annual Healthcare Conference on November 10, 2022.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences

Rhea-AI Summary

The Oncology Institute, Inc. (NASDAQ: TOI) announced that CEO Brad Hively and CFO Mihir Shah will speak at the Credit Suisse 31st Annual Healthcare Conference on November 10, 2022. Founded in 2007, TOI is a leading value-based oncology group in the U.S., providing specialized cancer care to about 1.7 million patients through over 50 clinics. The institute employs more than 90 clinicians and focuses on advanced, evidence-based treatment options.

Loading...
Loading translation...
Argus Session date unavailable
-8.59% session move Open Argus
Details

News Market Reaction – TOI

The recorded move for TOI in the trading session of this news was -8.59%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

CERRITOS, Calif., Nov. 01, 2022 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced that its Chief Executive Officer, Brad Hively, and its Chief Financial Officer, Mihir Shah, will participate in the Credit Suisse 31st Annual Healthcare Conference in Rancho Palos Verdes on Thursday, November 10.

About The Oncology Institute, Inc.

Founded in 2007, TOI is advancing oncology by delivering highly specialized, value-based cancer care in the community setting. TOI offers cutting-edge, evidence-based cancer care to a population of approximately 1.7 million patients including clinical trials, transfusions, and other care delivery models traditionally associated with the most advanced care delivery organizations. With 90+ employed clinicians and more than 700 teammates in over 50 clinic locations and growing, TOI is changing oncology for the better. For more information visit www.theoncologyinstitute.com.

Contacts

Media

The Oncology Institute
Julie Korinke
juliekorinke@theoncologyinstitute.com
(562) 735-3226 x 88806

Juan Lezama
juanlezama@theoncologyinstitute.com
(562) 374-8434

Investors

Solebury Trout
Maria Lycouris
investors@theoncologyinstitute.com


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is the date of The Oncology Institute's participation in the Credit Suisse 31st Annual Healthcare Conference?

The Oncology Institute will participate in the Credit Suisse 31st Annual Healthcare Conference on November 10, 2022.

Who will represent The Oncology Institute at the Credit Suisse Conference?

CEO Brad Hively and CFO Mihir Shah will represent The Oncology Institute at the conference.

What does The Oncology Institute specialize in?

The Oncology Institute specializes in value-based oncology care, providing treatment to approximately 1.7 million patients.

How many clinics does The Oncology Institute operate?

The Oncology Institute operates over 50 clinic locations across the United States.

What is the stock symbol for The Oncology Institute?

The stock symbol for The Oncology Institute is TOI.

What services does The Oncology Institute provide?

The Oncology Institute provides specialized cancer care, including clinical trials and transfusions.

Keep reading